Morgan Snyder is a pharmacist who is specialized in Psychiatric in Austin, Texas. Patients can reach her at 7603 Eastcrest Dr, Austin or contact her on 502-592-0258. Active license number of Morgan Snyder is 49056 for Psychiatric in Texas. Morgan Snyder is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Morgan Snyder speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Morgan Snyder
Specialization:
Psychiatric
Credentials:
PHARM.D.
Gender:
Female
Location:
7603 Eastcrest Dr, Austin, Texas, 78752-1409
Phone:
502-592-0258
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Morgan Snyder are as mentioned below.
NPI Number:
1407106750
NPI Enumeration Date:
13 Sep, 2012
NPI Last Update On:
13 Sep, 2012
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Morgan Snyder are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
49056
Texas
Primary
Psychiatric
014927
Kentucky
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
7603 Eastcrest Dr, Austin, Texas
Zip:
78752-1409
Phone Number:
502-592-0258
Fax Number:
--
Patients can reach Morgan Snyder at 7603 Eastcrest Dr, Austin, Texas or can call on phone at 502-592-0258.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.